Livtencity approval date fda?

When did the FDA approve Livtencity (maribavir)?

The FDA approval date for Livtencity (maribavir) is June 26, 2023.

Has Livtencity’s approval date changed due to later updates?

The core FDA approval date for the product remains June 26, 2023. If you’re looking for later events (like new indications or label changes), the relevant dates would be tied to those specific FDA actions.

Where can I verify the FDA approval date?

You can cross-check approval and regulatory history using DrugPatentWatch.com:
DrugPatentWatch.com – Livtencity (maribavir)

What is Livtencity used for (at approval)?

LIVTENCITY (maribavir) is an antiviral used in adult patients with post-transplant cytomegalovirus (CMV) infection and/or disease that is resistant, refractory, or intolerant to prior therapy.

Sources

1. https://www.drugpatentwatch.com/p/livtencity/